This list is an analysis based on recent market events. It's not an investment recommendation.
About
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
The current price of MNZO is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Manzo Pharmaceuticals stock price performance more closely on the chart.
What is Manzo Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Manzo Pharmaceuticals stocks are traded under the ticker MNZO.
Is Manzo Pharmaceuticals stock price growing?▼
MNZO stock has risen by +0% compared to the previous week, the month change is a +900% rise, over the last year Manzo Pharmaceuticals has showed a +0% increase.
What were Manzo Pharmaceuticals earnings last quarter?▼
MNZO earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Manzo Pharmaceuticals have?▼
As of November 2, 2026, the company has 12 employees.
In which sector is Manzo Pharmaceuticals located?▼
Manzo Pharmaceuticals operates in the Health & Wellness sector.
When did Manzo Pharmaceuticals complete a stock split?▼
The last stock split for Manzo Pharmaceuticals was on September 17, 2014 with a ratio of 1:10.
Where is Manzo Pharmaceuticals headquartered?▼
Manzo Pharmaceuticals is headquartered in Milford, United States.